Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9ZRN

Neutralizing W014 Fab antibody fragment in complex with West Nile Virus EDIII

Summary for 9ZRN
Entry DOI10.2210/pdb9zrn/pdb
DescriptorW014 Fab Heavy Chain, W014 Fab Light Chain, Envelope protein E, ... (4 entities in total)
Functional Keywordsantibody, neutralizing, west nile virus, viral protein, viral protein-immune system complex, viral protein/immune system
Biological sourceHomo sapiens
More
Total number of polymer chains3
Total formula weight59344.30
Authors
Contejean, Z.I.,Barnes, C.O. (deposition date: 2025-12-20, release date: 2026-07-29)
Primary citationCervantes Rincon, T.,Frckova, T.,Contejean, Z.I.,Cantergiani, J.,Groen, K.,Cena, B.,Moro, S.G.,Bianchini, F.,Simonelli, L.,Jarrossay, D.,Tosolini, S.,Kuratli, R.,Robinson, A.R.E.,Cizkova, M.,Niejadlik, E.G.,Moritz, J.,Thakur, R.,Kratka, Z.,Mijatovic, D.,Grujic, J.,Holoubek, J.,Budakov-Obradovic, Z.,Salat, J.,Honig, V.,Vranes, M.,Lojpur, Z.,Lendak, D.,Sevic, S.,Bajci, M.,Popovic-Dragonjic, L.,Popovska Jovicic, B.,Gavrilovic, J.,Kapoor, T.,MacDonald, M.R.,Bournazos, S.,Varani, L.,Palus, M.,Hale, B.G.,Banovic, P.,Ruzek, D.,Barnes, C.O.,Robbiani, D.F.
Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses.
Immunity, 59:2015-2029.e9, 2026
Cited by
PubMed Abstract: West Nile virus (WNV) is a mosquito-borne pathogen of global concern that can cause fatal neuroinvasive disease, and no specific prophylaxis or treatment exists for infections by WNV and most related orthoflaviviruses. Here, we isolated and characterized antibodies from WNV convalescent individuals and report that neutralizing autoantibodies against type I interferons did not impair antiviral antibody development. Among the monoclonal antibodies with potent neutralizing activity against WNV that were identified, W010 targeted a distinct epitope within the envelope protein domain III (EDIII) and conferred both pre- and post-exposure protection in a murine WNV model, even when interferon signaling was impaired. A second protective antibody, W014, exhibited broad cross-neutralization of other pathogenic orthoflavivirus members, including Japanese encephalitis virus, Murray Valley encephalitis virus, Saint Louis encephalitis virus, and Usutu virus. These findings identify key neutralizing epitopes on WNV EDIII and provide candidates for the development of antibody-based interventions against encephalitic orthoflavivirus infections.
PubMed: 42330958
DOI: 10.1016/j.immuni.2026.05.013
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

258009

PDB entries from 2026-08-12

PDB statisticsPDBj update infoContact PDBjnumon